TABLE 7.
Low-titer serum reproducibility for the ELISA used in this study with sera 513a and 516a
| Run | Operator | No. of replicates/run | No. of points/run | Within run
|
Between run
|
||
|---|---|---|---|---|---|---|---|
| %CVa | %CVb | %CVa | %CVb | ||||
| 513a | 1 | 4 | 1 | 10.5 | 23.8 | ||
| 1 | 5.8 | 25.7 | |||||
| 2 | 5.9 | 5.1 | |||||
| 3 | 4.5 | 13.1 | |||||
| 516a | |||||||
| Series 1 | 1 | 4 | 1 | 18.7 | 46.6 | ||
| 1 | 20.4 | 39.8 | |||||
| 2 | 15.9 | 23.6 | |||||
| 3 | 18.3 | 9.9 | |||||
| Series 2 | 30.1 | 34.6 | |||||
| 1 | 18.5 | 21.7 | |||||
| 2 | 18.9 | 22.4 | |||||
| 3 | 11.4 | 6.0 | |||||
a
Average of the individual point %CVs calculated by the absorbancy of each point.
b
Average of the individual point %CVs calculated by the absorbancy of each inhibited point.